Smisson-cartledge Biomedical's Unattributed - II Round

Smisson-cartledge Biomedical raised a round of funding on November 11, 2011.

Smisson-Cartledge Biomedical (SCB) is a medical device company focused on delivering a platform technology for providing temperature-controlled fluid therapies. SCB has developed a highly efficient he…

Articles about Smisson-cartledge Biomedical's Unattributed - II Round: